Glucosamine Supplement Linked to Accelerated Alzheimers Progression

Analyzing 12 years of deidentified patient electronic records using AI, researchers discovered that glucosamine use among individuals with Mild Cognitive Impairment (MCI) is associated with a 25% higher likelihood of progressing to full dementia, alongside a 25% spike in mortality for established Alzheimers patients.